688670.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 10:00):

Stats
Dzisiejszy wolumen	528 259
Średni wolumen	856 465
Kapitalizacja rynkowa	2.08B
EPS	CNY0 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-16.10
ATR14	CNY0.0170 (0.10%)

Wolumen Korelacja

Długi: -0.16 (neutral)

Krótki: -0.11 (neutral)

Signal:(41.816) Neutral

Jiangsu gdk Biotechnology Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jiangsu gdk Biotechnology Korelacja - Waluta/Towar

0.25
( neutral )

0.51
( weak )

0.00
( neutral )

0.46
( neutral )

-0.18
( neutral )

-0.37
( neutral )

Jiangsu gdk Biotechnology Finanse

Annual	2023
Przychody:	CNY139.97M
Zysk brutto:	CNY110.10M (78.66 %)
EPS:	CNY-0.540

FY	2023
Przychody:	CNY139.97M
Zysk brutto:	CNY110.10M (78.66 %)
EPS:	CNY-0.540

FY	2022
Przychody:	CNY318.49M
Zysk brutto:	CNY267.90M (84.12 %)
EPS:	CNY0.340

FY	2021
Przychody:	CNY392.27M
Zysk brutto:	CNY335.09M (85.42 %)
EPS:	CNY1.100

Financial Reports:

No articles found.

Jiangsu gdk Biotechnology

Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.